Nearly 76 percent of U.S. adults who reported feeling treated or judged unfairly in a healthcare setting within the 12 months prior to being surveyed said it caused care disruptions, according to findings from the Urban Institute published Aug. 9.
Patient Safety & Outcomes
While many studies have focused on the prevalence of long COVID-19 among adults, with estimates indicating between 10 percent and 30 percent of COVID-19 patients affected by lingering symptoms, not as much research has focused on how it affects children…
The American Academy of Physical Medicine and Rehabilitation has released the first clinical guidance on the treatment of post-COVID-19-related fatigue. It marks the first clinical guidance on treating long-haulers released since the CDC's interim guidance issued June 14.
CMS is preserving a critical patient safety measure in its Inpatient Quality Reporting Program after Leapfrog urged the agency to do away with a proposal to remove the measure.
A heart pump with a history of manufacturing and quality issues was implanted into thousands of patients even after the FDA was aware the device did not meet federal standards, according to an investigative report ProPublica published Aug. 5.
Advertisement
Nashville, Tenn.-based Vanderbilt University Medical Center's adult hospital is rescheduling surgeries that can be delayed amid a rise in COVID-19 patients, according to WPLN News.
Among 1,734 children in the U.K. with a COVID-19 infection, less than 5 percent had symptoms that lasted four weeks or longer, suggesting long COVID-19 is rarer in children than adults, according to research published Aug. 3 in The Lancet…
COVID-19 patients are younger and fitter, with American adults under age 50 accounting for 41 percent of COVID-19 hospitalizations, according to COVID-Net data.
The chief medical officers for Natchitoches (La.) Regional Medical Center and Our Lady of the Lake in Baton Rouge, La., on Aug. 2 said the state's COVID-19 surge is placing a large strain on their hospitals and hindering their ability…
Mild local and systemic reactions to Pfizer's COVID-19 vaccine are common among adolescents, while serious adverse events are rare, according to CDC data published July 30.